Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
'The fish that stop': drivers of historical decline for Pacific cod and implications for modern management in an era of rapidly changing climate.
McClenachan L, Anderson B, Addison J, Barbeaux S, Moore K, Muir K, Reedy K, Spies I, West CF. McClenachan L, et al. Among authors: addison j. Philos Trans R Soc Lond B Biol Sci. 2025 Jul 10;380(1930):20240278. doi: 10.1098/rstb.2024.0278. Epub 2025 Jul 10. Philos Trans R Soc Lond B Biol Sci. 2025. PMID: 40635437 Free PMC article.
Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
Fautrel B, Bouhnik Y, Salliot C, Carbonnel F, Fumery M, Bernardeau C, Maugars Y, Flamant M, Coury F, Braithwaite B, Hateb S, Addison J; PERFUSE investigators. Fautrel B, et al. Among authors: addison j. Drugs Real World Outcomes. 2025 Mar;12(1):163-164. doi: 10.1007/s40801-024-00477-4. Drugs Real World Outcomes. 2025. PMID: 39821191 Free PMC article. No abstract available.
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
Fautrel B, Bouhnik Y, Salliot C, Carbonnel F, Fumery M, Bernardeau C, Maugars Y, Flamant M, Coury F, Braithwaite B, Hateb S, Addison J; PERFUSE investigators. Fautrel B, et al. Among authors: addison j. Drugs Real World Outcomes. 2024 Dec;11(4):573-591. doi: 10.1007/s40801-024-00459-6. Epub 2024 Oct 10. Drugs Real World Outcomes. 2024. PMID: 39384685 Free PMC article.
224 results